News About: Goverment
Priority of NHI subsidy program for low income people.
The government announced that the NHI subsidy program would be given with priority to the low income people after reflecting it to the revised NHI Financial Stabilizing Act.
The MOHW made it clear that the NHI fina...
Government price review to save 58 BW by slashing l469 drugs by 9%
The NHI prices of 1,469 drugs produced by 186 companies seem to cut off by 9%, saving about 58 billion won a year.
The government completed the 2005 drug price review works and released them for the relevant drug c...
59 new drugs registered from 2003 to 2005.
It is reported that the total 59 new drugs had been registered in Korea during the past 3 years, and that the foreign multinational drug corporations imported such new drugs in a finished package form by 100% while th...
Amantadine drugs to prohibit for A flu treatment.
The medication of Amandatine or Remantadine preparations for the treatment or prevention of A type flu is not reimbursable by the NHI.
Recently, the KFDA recommended to physicians and pharmacists not to use the am...
KHIDI to run new drug supporting unit from next year.
The Korea Health Industry Development Institute (KHIDI) announced in the new year press interview on Jan. 23 that the Institute would run the National New Drug Support Center from the next year after preparing all nec...
Tough quality check on drugs of mid and lower GMP plants.
The KFDA reviewed the GMP plant practices last year and made a grade of them as the 4th (supplementation required) grade and the 5th grade (intensive control required) for a intensive quality control this year.
Th...
KFDA to reshuffle its organization.
The KFDA transformed its organization with an increase of 239 more officials as of Jan. 24, establishment of "Hazardous Substances Control Unit" and changing of the Test Team to Test and Analysis Center at the Gyeongi...
False and irregular medical bills on the rise.
False and irregular medical and NHI bills showed a rapidly rising trend.
To eliminate such illegal bills the MOHW plans to publicize the information about the government's compensational package for the report of ...
KFDA's guidelines on clinical test review in 5 therapeutic groups.
The clinical test review guideline in 5 therapeutic groups including anti-hypertension drugs seems to be prepared this year, which may help in great deal for the local clinical research level and the new drug developm...
222 new products newly listed to NHI scheme.
222 drugs will be listed to the NHI reimbursement schedule while 198 drugs (107 drugs of reimbursement and 91 of non reimbursement) deleted starting from Feb. 1 according to the MOHW ordinance of "NHI reimbursement an...
